Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.18 USD | +0.30% | -9.73% | -38.84% |
Financials (USD)
Sales 2024 * | 2.66B | Sales 2025 * | 2.76B | Capitalization | 2.23B |
---|---|---|---|---|---|
Net income 2024 * | -172M | Net income 2025 * | -117M | EV / Sales 2024 * | 0.94 x |
Net Debt 2024 * | 278M | Net Debt 2025 * | 75.83M | EV / Sales 2025 * | 0.84 x |
P/E ratio 2024 * |
-12.5
x | P/E ratio 2025 * |
-19.9
x | Employees | 5,208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.23% |
Latest transcript on Teladoc Health, Inc.
1 day | +0.30% | ||
1 week | -9.73% | ||
Current month | -12.72% | ||
1 month | -12.83% | ||
3 months | -33.60% | ||
6 months | -28.45% | ||
Current year | -38.84% |
Managers | Title | Age | Since |
---|---|---|---|
Mala Murthy
CEO | Chief Executive Officer | 60 | 19-06-23 |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 11-01-31 |
Nikolaos Nanis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Snow
CHM | Chairman | 69 | 14-01-31 |
Sandra Fenwick
BRD | Director/Board Member | 73 | 20-11-18 |
David Shedlarz
BRD | Director/Board Member | 75 | 16-09-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.31% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 13.18 | +0.30% | 4,035,574 |
24-04-17 | 13.14 | +0.08% | 3,948,423 |
24-04-16 | 13.13 | -3.10% | 4,898,635 |
24-04-15 | 13.55 | -4.64% | 6,416,014 |
24-04-12 | 14.21 | -2.67% | 4,933,513 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.84% | 2.23B | |
+38.65% | 2.64B | |
+16.93% | 502M | |
+42.77% | 467M | |
-65.24% | 153M | |
-33.67% | 82.92M |
- Stock Market
- Equities
- TDOC Stock